Pharmaceuticals, Biotechnology and Life Sciences
First OpRegen Patient Dosed at Cincinnati Eye Institute CARLSBAD, Calif.–(BUSINESS WIRE)–$LCTX #AMD—Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX),…
Open-label extension of the FOCUS Phase IIIb study examined changes in quality of life, health status, depressive symptoms and work…
– Alpine Immune Sciences grants AbbVie option to license worldwide rights to ALPN-101, a phase 2-ready, first-in-class dual CD28/ICOS costimulation…
IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Urovant Sciences (Nasdaq: UROV) today announced it has entered into an exclusive three-year distribution agreement…
BURLINGTON, Mass.–(BUSINESS WIRE)–scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to…
– Effector Function Enhanced Anti-TIGIT Antibody – – Antibody-Drug Conjugate Targeting Integrin Beta-6 – – Both Drug Candidates to be…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, will host a webcast…
Poised for pivotal lung transplant trial in U.S. CHAPEL HILL, N.C.–(BUSINESS WIRE)–Renovion, Inc., a biopharmaceutical company on a mission to…
LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)…
CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid…